Demant A/S Unsponsored ADR (OTCMKTS:WILYY) Short Interest Down 28.9% in March

Demant A/S Unsponsored ADR (OTCMKTS:WILYY) was the target of a significant drop in short interest during the month of March. As of March 31st, there was short interest totaling 118 shares, a drop of 28.9% from the March 15th total of 166 shares. Currently, 0.0% of the shares of the company are sold short. Based on an average daily trading volume, of 48 shares, the short-interest ratio is currently 2.5 days.

Demant A/S Stock Performance

OTCMKTS:WILYY opened at $14.96 on Tuesday. Demant A/S has a 1-year low of $13.45 and a 1-year high of $21.93. The company’s fifty day moving average price is $14.17 and its 200-day moving average price is $16.15. The company has a current ratio of 1.36, a quick ratio of 1.00 and a debt-to-equity ratio of 1.65.

Analyst Upgrades and Downgrades

Separately, Jefferies Financial Group raised shares of Demant A/S from a “hold” rating to a “strong-buy” rating in a report on Wednesday, March 18th. Two investment analysts have rated the stock with a Strong Buy rating and one has issued a Hold rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Buy”.

About Demant A/S

Demant A/S is a Denmark-based global hearing health care company specializing in the development, manufacture and distribution of hearing solutions and audiological diagnostic instruments. The company’s flagship brands include Oticon, Bernafon and Sonic, which offer a range of hearing aids designed to address various levels of hearing loss. In addition to personal hearing devices, Demant provides diagnostic equipment such as audiometers and tympanometers, supporting hearing care professionals in accurate assessment and fitting of hearing solutions.

Beyond hearing aids and diagnostics, Demant’s product portfolio extends to hearing implants—cochlear and bone-anchored systems—through its Oticon Medical division.